ICD-10-CM Code for Sickle-cell disorders D57.
V78. 2 - Screening for sickle-cell disease or trait | ICD-10-CM.
U07. 1 will be added to the category “Other and unspecified infectious and parasitic diseases and their sequelae” (cause number 17). A new line for “COVID-19” (with ICD-10 code U07.
Z20. 828, Contact with and (suspected) exposure to other viral communicable diseases. Use this code when you think a patient has been exposed to the novel coronavirus, but you're uncertain about whether to diagnose COVID-19 (i.e., test results are not available).
Sickle-cell/Hb-C disease with crisis, unspecified D57. 219 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2022 edition of ICD-10-CM D57. 219 became effective on October 1, 2021.
V78. 0 - Screening for iron deficiency anemia | ICD-10-CM.
R05.1 Acute cough.
CPT codes 0004A, 0054A, and 0064A are used to report the administration of a booster dose of the Pfizer and Moderna vaccine products. These codes represent the administration of a vaccine product when the initial immune response to a primary vaccine series was sufficient but has likely waned over time.
For asymptomatic individuals with actual or suspected exposure to COVID-19, assign code Z20. 822. For symptomatic individuals with actual or suspected exposure to COVID-19 and the infection has been ruled out, or test results are inconclusive or unknown, assign code Z20. 822.
For example, Z11. 52 will replace Z11. 59 (Encounter for screening for other viral diseases), which the CDC previously said should be used when patients being screened for COVID-19 have no symptoms, no known exposure to the virus, and test results that are either unknown or negative.
These codes are therefore an assumption of how it was likely being reported. Note: The new code Z11. 52 (Encounter for screening for COVID-19) effective 1/1/21, is not appropriate for screening until the pandemic is declared over (per January 2021 updated guidelines I.C.